跳至主要内容
临床试验/IRCT201511058022N3
IRCT201511058022N3已完成未知

Bioequivalency study of two different gabapentin formulations

Sobhan Daru pharmaceutical company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
All

入选标准

  • 24 healthy male and female volunteers will participate in this study. Aged 18 to 45 years, based on laboratory safety tests, no history of diseases affecting drug pharmacokinetic processes; lack of any chronic or acute medication at least 1 week before the start of the study, adherence to the criteria on the basis of moral obligation and signed an informed consent; actual weight (TBW) in the range of 20% IBW
  • Exclusion criteria:
  • Age outside the range mentioned; acute or chronic smoking or alcohol, failure to obtain any of the above health tests, medication two weeks before the experiment

排除标准

  • 未提供

研究者

发起方
Sobhan Daru pharmaceutical company

相似试验

Comparative study on the bioequivalence of two... | 临床试验